The major defining pathological hallmark of Alzheimer's disease (AD) is the accumulation of amyloid beta protein (Abeta), a small peptide derived from beta- and gamma-secretase cleavages of the amyloid precursor protein (APR). The production of Abeta requires APR endocytosis and subsequent trafficking to intracellular compartments where the proteolytic enzymatic activities reside. Recently, it was demonstrated that both beta- and gamma-secretase activities of BACE1 and presenilins, respectively, are concentrated in cholesterol-rich lipid raft microdomains wherein Abeta is generated. However, the mechanism by which APP is sorted to lipid rafts is unknown. Increasing evidence suggests that the Low-density lipoprotein receptor- related protein (LRP) facilitates amyloidogenic processing of APP, although the precise mechanism underlying this activity is still unclear. We recently demonstrated that the soluble cytoplasmic tail of LRP (LRP-ST) without a membrane tether is sufficient to elevate Abeta production by increasing BACE cleaved APP beta-CTF. This led us to hypothesize that LRP-ST might function to facilitate the intracellular sorting of APP and/or BACE into lipid raft membranes. Indeed, our preliminary results have confirmed this very prediction and provided strong evidence the endogenous LRP also normally functions to faciliate APP sorting to lipid rafts. We hypothesize that LRP within the cytoplasmic tail contains a lipid raft-targeting domain separate from the APP binding domain that enhances sorting of APP to lipid rafts. In this proposal, we aim to dissect the sequences in LRP-ST required for its physical association with lipid raft membranes and utilize this information to direct APP sorting away from lipid rafts and screen for candidate proteins responsible for lipid raft localization of LRP. The cellular and biochemical mechanisms by which Abeta is generated is critical for designing therapeutic strategies for AD. One potential therapeutic design might be to inhibit the sorting of APP to lipid raft microdomains where Abeta is generated. Based on our results, LRP is the first pathway in which the trafficking of APP to lipid rafts is affected. Thus, understanding the nature of LRP/lipid raft interaction via identification of the raft targeting sequence and interacting raft targeting protein(s) might yield important information as to how APP trafficking can be therapeutically modified to inhibit Abeta generation. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
3P50AG005131-24S1
Application #
7176546
Study Section
National Institute on Aging Initial Review Group (NIA)
Program Officer
Phelps, Creighton H
Project Start
1997-04-01
Project End
2009-03-31
Budget Start
2007-08-15
Budget End
2008-03-31
Support Year
24
Fiscal Year
2007
Total Cost
$79,079
Indirect Cost
Name
University of California San Diego
Department
Neurosciences
Type
Schools of Medicine
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Burke, Shanna L; Hu, Tianyan; Fava, Nicole M et al. (2018) Sex differences in the development of mild cognitive impairment and probable Alzheimer's disease as predicted by hippocampal volume or white matter hyperintensities. J Women Aging :1-25
Wang, Qi; Guo, Lei; Thompson, Paul M et al. (2018) The Added Value of Diffusion-Weighted MRI-Derived Structural Connectome in Evaluating Mild Cognitive Impairment: A Multi-Cohort Validation1. J Alzheimers Dis 64:149-169
Sundermann, Erin E; Tran, My; Maki, Pauline M et al. (2018) Sex differences in the association between apolipoprotein E ?4 allele and Alzheimer's disease markers. Alzheimers Dement (Amst) 10:438-447
Besser, Lilah; Kukull, Walter; Knopman, David S et al. (2018) Version 3 of the National Alzheimer's Coordinating Center's Uniform Data Set. Alzheimer Dis Assoc Disord 32:351-358
Graves, Lisa V; Van Etten, Emily J; Holden, Heather M et al. (2018) Refining CVLT-II recognition discriminability indices to enhance the characterization of recognition memory changes in healthy aging. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn 25:767-782
Edmonds, Emily C; Weigand, Alexandra J; Thomas, Kelsey R et al. (2018) Increasing Inaccuracy of Self-Reported Subjective Cognitive Complaints Over 24 Months in Empirically Derived Subtypes of Mild Cognitive Impairment. J Int Neuropsychol Soc 24:842-853
Crum, Jana; Wilson, Jeffrey; Sabbagh, Marwan (2018) Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer's dementia? Alzheimers Res Ther 10:104
Wang, Tingyan; Qiu, Robin G; Yu, Ming (2018) Predictive Modeling of the Progression of Alzheimer's Disease with Recurrent Neural Networks. Sci Rep 8:9161
Burke, Shanna L; Cadet, Tamara; Maddux, Marlaina (2018) Chronic Health Illnesses as Predictors of Mild Cognitive Impairment Among African American Older Adults. J Natl Med Assoc 110:314-325
González, Hector M; Tarraf, Wassim; Vásquez, Priscilla et al. (2018) Metabolic Syndrome and Neurocognition Among Diverse Middle-Aged and Older Hispanics/Latinos: HCHS/SOL Results. Diabetes Care 41:1501-1509

Showing the most recent 10 out of 914 publications